February 23, 2021
Fitbit has tapped alternative medicine advocate Dr. Deepak Chopra to headline a collection of wellness content for Fitbit Premium members.
Called "Deepak Chopra's Mindful Method for Fitbit," the offering launches with 10 sessions focused on topics such as mindfulness, breathing, stress management and sleep, with additional sessions coming every couple of weeks up to the beginning of June, Fitbit...
August 15, 2019
This morning MyHealthTeams, a social network for chronic care patients, announced exclusively to MobiHealthNews that it landed $9.44 million in Series B funding. This round was led by Belgian pharma giant UCB, who has teamed up with MyHealthTeams on a number of initiatives in the past, notably on creating a spondyloarthritis focused social network.
Adams Street Partners, Qiming US Ventures, CVS...
July 8, 2019
Pharmaceutical company UCB and DEARhealth, a disease management software company, are joining forces on a new initiative aimed at predicting health outcomes for patients with epilepsy. The pair will use DEARhealth’s platform, which integrates artificial intelligence with EHRs.
“This technology will ensure that specific subpopulations within epilepsy will all receive the specific care needed for...
July 3, 2019
Diving deeper into digital, this quarter the pharma giants have continued to implement new tools to enhance clinical trials, support medication management with technology and partner in developing digital therapeutics.
Onc, a foreign entity to this established industry, pharma executives are now becoming better versed in working with digital health companies and sharing the lessons they've...
June 12, 2019
As more stakeholders enter the digital health arena looking to partner, miscommunications and misconceptions are increasingly common. In order to circumvent this potential Tower of Babel problem, collaboration and shared goals are essential, according to speakers on the Pharma Innovation Beyond the Pill panel at Health 2.0 Europe in Helsinki today.
While there are pitfalls in any partnership,...
December 26, 2018
The pharma industry has become increasingly interested in the digital health space over the last few years, but this quarter numerous projects that have been in the works for years have finally came to fruition. For instance, Pear's reSET, the first digital therapeutic cleared by the FDA, was recently launched to commercial markets.
But that wasn’t the only advance in the space as pharma...
November 15, 2018
Belgian biopharma company UCB has tapped customer engagement company Verint Systems to create an app for patients with Parkinson's disease. The app is called PD Coach and includes an AI assistant named April which can communicate with users either by text or speech.
At launch, the app will support journaling and symptoms tracking. April is programmed with a wealth of Parkinson's-specific...
June 28, 2018
Over a year ago Partners Health and biopharmaceutical company UCB teamed up to tackle a moonshot goal: make Boston the best city to live in for people with epilepsy. So the team decided that in order to design a digital health platform to support this task, it was vital to go to patients for input and ideas.
“We want to be patient centric, but what does patient centric mean?” Dr. Kamal Jethwani...
May 3, 2018
Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in detecting and managing medical conditions, the groups announced earlier this week. Initially focused on sleep apnea and atrial fibrillation, the collaboration is a clear step beyond the fitness and wellness realm to which Garmin’s wearables have so far been limited.
“Garmin Health is...
January 18, 2018
San Francisco-based MyHealthTeams has added its 28th disease-specific social network, and is working with Belgian pharmaceutical company UCB on an educational inititative related to the platform.
MySpondylitisTeam, the newest network, is aimed at patients with spondyloarthritis, a kind of arthritis which, unlike rheumatoid arthritis, tends to first present itself when patients are in their 20s...